Literature DB >> 19248087

The early disease stage in axial spondylarthritis: results from the German Spondyloarthritis Inception Cohort.

Martin Rudwaleit1, Hildrun Haibel, Xenofon Baraliakos, Joachim Listing, Elisabeth Märker-Hermann, Henning Zeidler, Jürgen Braun, Joachim Sieper.   

Abstract

OBJECTIVE: Ankylosing spondylitis (AS) is diagnosed late, because radiographs of the sacroiliac joints often do not show definite sacroiliitis at the time of disease onset. The aim of this study was to investigate whether patients without definite radiographically defined sacroiliitis, referred to as nonradiographic axial spondylarthritis (SpA), are different from patients with AS with regard to clinical manifestations and disease activity measures. Moreover, we sought to identify determinants of the development of radiographic sacroiliitis.
METHODS: In a cross-sectional analysis of 462 patients, we compared 226 patients with nonradiographic axial SpA (symptom duration < or =5 years) and 236 patients with AS (symptom duration < or =10 years) who are participants in the German Spondyloarthritis Inception Cohort. Radiographs of the sacroiliac joints and the spine were assessed by 2 readers in a blinded manner. Logistic regression analysis was applied to identify parameters associated with structural damage.
RESULTS: The 2 groups did not differ in the frequency of HLA-B27 positivity, inflammatory back pain, arthritis, enthesitis, and uveitis and had similar levels of disease activity, using measures such as the Bath Ankylosing Spondylitis Disease Activity Index. In both groups, HLA-B27 positivity determined the age at disease onset. Male sex (adjusted odds ratio [OR] 2.38, 95% confidence interval [95% CI] 1.19-4.73 [P = 0.014]) and an elevated C-reactive protein (CRP) level (adjusted OR 1.85, 95% CI 0.96-3.56 [P = 0.066]) were associated with radiographic sacroiliitis. In patients with AS, male sex and an elevated CRP level were also associated with the presence of syndesmophytes.
CONCLUSION: Clinical manifestations and disease activity measures are highly comparable between patients with early nonradiographic axial SpA and those with early AS, suggesting that these 2 entities are part of the same disease. Male sex and an elevated CRP level are associated with structural damage on radiographs, whereas HLA-B27 positivity determines the age at disease onset.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19248087     DOI: 10.1002/art.24483

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  197 in total

Review 1.  Unmet Needs in Axial Spondyloarthritis.

Authors:  Ennio Lubrano; Antonia De Socio; Fabio Massimo Perrotta
Journal:  Clin Rev Allergy Immunol       Date:  2018-12       Impact factor: 8.667

Review 2.  'MRI-tis' in the early diagnosis of axial SpA: issues and limitations.

Authors:  Leen De Rycke; Mario Maas; Paul P Tak; Dominique Baeten
Journal:  Nat Rev Rheumatol       Date:  2010-10-05       Impact factor: 20.543

3.  Improvement in pain intensity, spine stiffness, and mobility during a controlled individualized physiotherapy program in ankylosing spondylitis.

Authors:  Zsuzsanna Némethné Gyurcsik; Anita András; Nóra Bodnár; Zoltán Szekanecz; Sándor Szántó
Journal:  Rheumatol Int       Date:  2011-12-25       Impact factor: 2.631

4.  Ankylosing spondylitis - the changing role of imaging.

Authors:  Zoe Ash; Helena Marzo-Ortega
Journal:  Skeletal Radiol       Date:  2012-09       Impact factor: 2.199

5.  [Early axial spondyloarthritis. Diagnostic approach and screening].

Authors:  D Poddubnyy; M Rudwaleit; J Sieper
Journal:  Z Rheumatol       Date:  2012-01       Impact factor: 1.372

6.  Polymorphisms of human leukocyte antigen B*27 on clinical phenotype of spondyloarthritis in Chinese.

Authors:  Hai-Jun Ma; Qing-Feng Yin; Yun Liu; Yin Wu; Tie-Chui Zhu; Ming-Hao Guo
Journal:  J Clin Lab Anal       Date:  2017-06-20       Impact factor: 2.352

Review 7.  [Identification of patients with axial spondylarthritis in primary care (AWARE study)].

Authors:  J Braun; T Mosch; I Fischer; U Kiltz
Journal:  Z Rheumatol       Date:  2019-08       Impact factor: 1.372

Review 8.  Spontaneous, drug-induced, and drug-free remission in peripheral and axial spondyloarthritis.

Authors:  Denis Poddubnyy; Lianne S Gensler
Journal:  Best Pract Res Clin Rheumatol       Date:  2014-11-10       Impact factor: 4.098

Review 9.  Golimumab for the treatment of ankylosing spondylitis: a NICE single technology appraisal.

Authors:  Nigel Armstrong; Manuela Joore; Thea van Asselt; Kate Misso; Nathan Manning; Florian Tomini; Jos Kleijnen; Rob Riemsma
Journal:  Pharmacoeconomics       Date:  2013-05       Impact factor: 4.981

Review 10.  The ASAS Criteria for Axial Spondyloarthritis: Strengths, Weaknesses, and Proposals for a Way Forward.

Authors:  Sjef van der Linden; Nurullah Akkoc; Matthew A Brown; Philip C Robinson; Muhammad A Khan
Journal:  Curr Rheumatol Rep       Date:  2015-09       Impact factor: 4.592

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.